{"disease":{"id":"muscular-dystrophy-duchenne","name":"muscular dystrophy duchenne"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03443115","title":"Duchenne Muscular Dystrophy Heart Study","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Hôpital Cochin","has_results":false},{"nct_id":"NCT07511920","title":"A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"West China Second University Hospital","has_results":false},{"nct_id":"NCT03179631","title":"Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT02369731","title":"Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)","phase":"","overall_status":"COMPLETED","enrollment_count":316,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT01826487","title":"Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT02090959","title":"An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":219,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT03992430","title":"A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Sarepta Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05066633","title":"The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Medical University of Gdansk","has_results":false},{"nct_id":"NCT03703882","title":"Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Catabasis Pharmaceuticals","has_results":true},{"nct_id":"NCT05715957","title":"Follow-up Study on Female Carriers With DMD Gene Variants","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":103,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT02834650","title":"Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD","phase":"NA","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04626674","title":"A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":83,"lead_sponsor_name":"Sarepta Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07287189","title":"Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":51,"lead_sponsor_name":"Satellos Bioscience, Inc.","has_results":false},{"nct_id":"NCT06833489","title":"Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT03400852","title":"A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"Mallinckrodt ARD LLC","has_results":true},{"nct_id":"NCT03769116","title":"A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Sarepta Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06244082","title":"Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":39,"lead_sponsor_name":"Avidity Biosciences, Inc.","has_results":false},{"nct_id":"NCT03127241","title":"User-centred Assistive System for Arm Functions in Neuromuscular Subjects","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Politecnico di Milano","has_results":false},{"nct_id":"NCT03789734","title":"Safety Study of BLS-M22 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"BioLeaders Corporation","has_results":false},{"nct_id":"NCT06363357","title":"The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05688072","title":"Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05209087","title":"Effects of Parental Influence on Physical Activity Level and Participation in Children With Duchenne Muscular Dystrophy","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT06337669","title":"Characterization of DupEx2 Duchenne Muscular Dystrophy","phase":"","overall_status":"UNKNOWN","enrollment_count":26,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT04669847","title":"The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Gokce Yagmur Gunes Gencer","has_results":false},{"nct_id":"NCT05833633","title":"Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03406780","title":"A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Capricor Inc.","has_results":true},{"nct_id":"NCT03490214","title":"Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT03375255","title":"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Sarepta Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03675126","title":"An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Sarepta Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03879304","title":"Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker.","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of Malaga","has_results":false},{"nct_id":"NCT03963453","title":"Regular Physical Exercise in Duchenne Muscular Dystrophy","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT05429372","title":"Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03777319","title":"Spironolactone Versus Prednisolone in DMD","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Kevin Flanigan","has_results":true},{"nct_id":"NCT04337112","title":"The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"NS Pharma, Inc.","has_results":false},{"nct_id":"NCT07250737","title":"Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Avidity Biosciences, Inc.","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}